AlphaCentric Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-295,000
Closed -$2.97M 242
2023
Q2
$2.97M Buy
295,000
+80,000
+37% +$742K 1.65% 10
2023
Q1
$2.02M Buy
215,000
+112,500
+110% +$1.33M 1.39% 17
2022
Q4
$1.25M Buy
102,500
+25,000
+32% +$312K 1.24% 21
2022
Q3
$962K Buy
+77,500
New +$1.35M 0.99% 26

Other funds holding ELAN

AlphaCentric Advisors's ELAN Position: Q3 2023 in Review

AlphaCentric Advisors sold out of Elanco Animal Health (ELAN) in Q3 2023, closing a stake of 295,000 shares — an estimated $2.97M sold.

AlphaCentric Advisors first reported a position in ELAN in Q3 2022 and held it in 4 quarters. The position peaked at $2.97M in Q2 2023. 350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

  • AlphaCentric Advisors reported no remaining Elanco Animal Health position as of Q3 2023 after selling out during the quarter.
  • AlphaCentric Advisors sold 295,000 Elanco Animal Health shares in Q3 2023, an estimated $2.97M.
  • AlphaCentric Advisors first reported a position in Elanco Animal Health in Q3 2022 and held it in 4 quarters.
  • AlphaCentric Advisors's Elanco Animal Health position peaked at $2.97M in Q2 2023.
  • 350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.